Hence the loss of p53 and consequent removal of PML from these ER membrane subdomains provides a mean to promote tumor growth, by increasing resistance to apoptotic stimuli and increasing adaptation to metabolic stress and anticancer therapy-mediated cellular damage, by stimulating autophagy (Missiroli et al., 2016). This evidence concerns the gene TP53 and neoplasm.